CELESTONE SOLUSPAN — FDA application NDA014602
Listed sponsor: ORGANON · OGN company profile · exact_unique
Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.
FDA application facts
| Product | FDA-listed trade name | Active ingredient | Dosage form | Route | Strength | Marketing status | TE code | RLD |
|---|---|---|---|---|---|---|---|---|
| 001 | CELESTONE SOLUSPAN | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE | INJECTABLE | INJECTION | 3MG/ML;EQ 3MG BASE/ML | Prescription | AB | Yes |
Product, form, strength, reference-drug and marketing-status fields: Drugs@FDA data files; TE and RLD fields: Orange Book data files. Retrieved 2026-08-07.
Orange Book patent and exclusivity listings
No Orange Book patent or exclusivity listings joined to this application.
Compound cross-links
- BETAMETHASONE ACETATE · UNII TI05AO53L7 · lmmol compound AKUJBENLRBOFTD-QZIXMDIESA-N · CHEMBL1200538
- BETAMETHASONE SODIUM PHOSPHATE · UNII 7BK02SCL3W · lmmol compound PLCQGRYPOISRTQ-LWCNAHDDSA-L · CHEMBL1200762
Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.
Related pages
Sponsor company · FDA-approved application index
Peer clusters: No published peer-cluster link for this sponsor.
Sources: Drugs@FDA · Orange Book · openFDA application record. FDA data retrieved 2026-08-07.
Regulatory listing data as published by FDA; not medical or investment advice.